Wearables and machine learning to spot infections early in children and teens with cancer
Official title: WEARABLES: Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
Run by Murdoch Childrens Research Institute · NCT07030998 · Data updated 2026-11-12
This project will try to use data from wearable devices and machine learning to detect infections earlier in children and adolescents receiving cancer treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 18 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Murdoch Childrens Research Institute Academic / other |
| Locations | 1 site (Parkville, Victoria) |
| Status | Recruiting |
| Started | October 15, 2025 |
| Main results expected | August 2027 |
| Study ends | December 2027 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT07030998 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and young people aged 5–18 receiving cancer treatment at The Royal Children's Hospital who can wear an Apple Watch for four weeks and have an iPhone 8 or later are ideal candidates.
✕Probably not a fit
Children under 5, those unable or unwilling to wear the Apple Watch, those without a compatible iPhone, or patients not receiving care at the enrolling hospital will not be eligible and are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a non‑interventional, silent pilot that passively collects wearable data from children and adolescents aged 5–18 undergoing cancer therapy at The Royal Children's Hospital. Participants wear an Apple Watch during waking hours for about 4 weeks while the study app on a compatible iPhone records physiological signals and activity. The collected data will be used to train machine learning models to identify patterns that may precede infection or fever by up to 72 hours. No treatments are assigned by the study; the goal is to build and validate a predictive model for future clinical use.
Why it matters
Potential benefit: If successful, earlier detection could allow faster treatment and reduce severe infection-related complications and hospital stays.
How similar studies have gone: Preliminary work and pilot studies have shown that wearable signals can precede fever onset, but using machine learning specifically for infection prediction in pediatric oncology remains largely experimental.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Paediatric, adolescent or young adult diagnosis of cancer AND receiving therapy placing them at risk of infection * Receiving cancer treatment at The Royal Children's Hospital * Patients aged 5-18 years at time of the eligibility screening * If aged \< 16 years, parent or guardian able to provide consent * iPhone 8 or later (iOS must be up to date/updated at time of enrolment) * At least 10MB of iPhone storage for WEARABLES app and data collection. * Willing and able to wear a wearable device for a period of 4 weeks (during waking hours). * Consent to data being shared to the WEARABLES app (owned by the research team). Exclusion Criteria: * \<5 years of age. * \<16 years of age without guardian or parent consent. * Aged 16-18 and unable to provide consent. * Participant did not consent to wearing Apple Watch for a period of 4 weeks.
Where it's running
-
The Royal Children's Hospital
Parkville, Victoria, Australia Recruiting
Study contacts
- Study coordinator: Lane Collier
- Email: lane.collier@mcri.edu.au
- Phone: 03 9936 6324
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
Digitally Enabled Districts 2.0: Aimed at Improving Maternal and Neonatal Care in Garut
A stepped-wedge trial tests whether an integrated digital health ecosystem helps 45 local clinics in Garut improve the completeness and timeliness of maternal and neonatal care.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit
This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.
-
Wearable Blood Pressure Monitoring Comparison
This study tests whether wearable devices like smartwatches can accurately measure blood pressure compared with standard cuff measurements and arterial lines in hospitalized patients.
-
Continuous Vital Sign Monitoring in a Gastro-surgical Ward
This study tests whether wearing sensors that continuously track vital signs helps detect deterioration earlier for adults on a gastro-surgical ward, in addition to standard NEWS-2 monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.